Adaptimmune Therapeutics shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $186k | 1.5M | 0.13 |
| 2025-06-30 | $459k | 2.0M | 0.23 |
| 2025-03-31 | $424k | 2.2M | 0.19 |
| 2024-12-31 | $269k | 510k | 0.53 |
| 2023-06-30 | $329k | 358k | 0.92 |
| 2023-03-31 | $332k | 311k | 1.07 |
| 2022-12-31 | $760k | 526k | 1.45 |
| 2022-09-30 | $116k | 112k | 1.04 |
| 2022-06-30 | $23k | 14k | 1.69 |
| 2022-03-31 | $91k | 44k | 2.06 |
| 2020-12-31 | $1.6M | 301k | 5.39 |
| 2019-06-30 | $170k | 43k | 4.00 |
| 2019-03-31 | $83k | 19k | 4.28 |
| 2018-12-31 | $219k | 38k | 5.75 |
| 2018-03-31 | $309k | 28k | 11.23 |
| 2017-12-31 | $108k | 16k | 6.70 |
| 2017-09-30 | $206k | 25k | 8.20 |